Ekso Bionics Receives Final Payment Determination For Medicare Reimbursement From Centers For Medicare & Medicaid Services For Ekso Indego Personal; Final Payment Level Of $91,031.93
Portfolio Pulse from Benzinga Newsdesk
Ekso Bionics has received the final payment determination for Medicare reimbursement from the Centers for Medicare & Medicaid Services for its Ekso Indego Personal product. The final payment level has been set at $91,031.93.
April 12, 2024 | 12:04 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Ekso Bionics' final Medicare reimbursement rate for Ekso Indego Personal has been established at $91,031.93, indicating a positive development for the company's revenue prospects.
The final payment determination from the Centers for Medicare & Medicaid Services is a critical regulatory milestone that directly impacts Ekso Bionics' revenue potential and market penetration for the Ekso Indego Personal. This positive development is likely to be viewed favorably by investors, potentially leading to an uptick in the company's stock price in the short term.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100